US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 18.900
- +2.050+12.17%
Close May 8 16:00 ET
- 19.170
- +0.270+1.43%
Pre 08:25 ET
2.70BMarket Cap-20106P/E (TTM)
20.250High17.000Low2.70MVolume17.000Open16.850Pre Close51.24MTurnover2.19%Turnover RatioLossP/E (Static)142.61MShares33.31052wk High1.85P/B2.33BFloat Cap14.56052wk Low--Dividend TTM123.16MShs Float93.940Historical High--Div YieldTTM19.29%Amplitude12.320Historical Low18.961Avg Price1Lot Size
Denali Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Apr 30, 2024
The average Denali Therapeutics stock price target is 46.11 with a max estimate of 95.00 and a min estimate of 27.00
Review Denali Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Apr 30, 2024
Heat List
US
Overall
Symbol
Latest Price
%Chg
